0001104659-22-097621.txt : 20220902
0001104659-22-097621.hdr.sgml : 20220902
20220902212829
ACCESSION NUMBER: 0001104659-22-097621
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220901
FILED AS OF DATE: 20220902
DATE AS OF CHANGE: 20220902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Mahony John Mark
CENTRAL INDEX KEY: 0001808556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37990
FILM NUMBER: 221226686
MAIL ADDRESS:
STREET 1: C/O LEAP THERAPEUTICS, INC.
STREET 2: 47 THORNDIKE STREET, SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509745
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274412575
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 252 4343
MAIL ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Dekkun Corp
DATE OF NAME CHANGE: 20110107
4
1
tm2225099-10_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-09-01
0
0001509745
LEAP THERAPEUTICS, INC.
LPTX
0001808556
O'Mahony John Mark
C/O LEAP THERAPEUTICS, INC.
47 THORNDIKE STREET SUITE B1-1
CAMBRIDGE
MA
02141
0
1
0
0
Chief Manufacturing Officer
Employee Stock Option (Right to Buy)
1.43
2022-09-01
4
A
0
200000
0
A
2032-08-31
Common Stock
200000
200000
D
The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of September 1, 2022, the Vesting Start Date.
/s/ Douglas E. Onsi, as attorney-in-fact for John Mark O'Mahony
2022-09-02